Pepbloc FG


Formulation : H-Gly-Pro-Arg-Pro-OH; AcOH

MW(Da) : 485.5
Pepbloc FG binds to fibrinogen to inhibit polymerization of the fibrin network, thereby disrupting the mechanical properties of the clot.
Inhibits fibrin formation and turbidity of the fibrin network.

Reference 6-INH-FG-5 
Presentation Vial 
Packaging 3 x 50 mg 
Price list, safety data sheets and notices are accessible to our registered customers.